Literature DB >> 16293925

Leukemoid reaction in association with bone marrow necrosis due to metastatic prostate cancer.

Taichi Azuma1, Ikuya Sakai, Takuya Matsumoto, Akira Ozawa, Nozomu Tanji, Akito Watanabe, Naoyuki Uchida, Hirosi Narumi, Yoshihiro Yakushijin, Takaaki Hato, Masaki Yasukawa, Shigeru Fujita.   

Abstract

An 80-year-old man presented to the internist with fever, fatigue and leukocytosis up to 66.8 x 10(3)/microl. Although a chronic myelogenous leukemia was initially suspected, he was diagnosed as metastatic bone marrow tumor with bone marrow necrosis from primary prostate cancer on the basis of the clinical and pathological findings. The serum concentrations of IL-6 and TNF-alpha were mildly elevated to 65.0 pg/ml and, 54.0 pg/ml respectively. It is probable that these humoral factors were partially responsible for the leukemoid reaction although other factors induced by the bone marrow necrosis with bone marrow metastasis of prostate cancer are also likely involved.

Entities:  

Mesh:

Year:  2005        PMID: 16293925     DOI: 10.2169/internalmedicine.44.1093

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Paraneoplastic Leukemoid Reaction after Primary Tumor Resection in Patients with Urothelial Carcinoma: A Report of 2 Cases.

Authors:  Shien-Tung Pan; Shu-Ping Tseng; Chiou-Huey Wang; Yu-Ting Chou
Journal:  Clin Pathol       Date:  2021-07-12

2.  Characterization of a novel automated microfiltration device for the efficient isolation and analysis of circulating tumor cells from clinical blood samples.

Authors:  Juan F Yee-de León; Brenda Soto-García; Diana Aráiz-Hernández; Jesús Rolando Delgado-Balderas; Miguel Esparza; Carlos Aguilar-Avelar; J D Wong-Campos; Franco Chacón; José Y López-Hernández; A Mauricio González-Treviño; José R Yee-de León; Jorge L Zamora-Mendoza; Mario M Alvarez; Grissel Trujillo-de Santiago; Lauro S Gómez-Guerra; Celia N Sánchez-Domínguez; Liza P Velarde-Calvillo; Alejandro Abarca-Blanco
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.